No Picture
Uncategorized

CELL BIOLOGIST/CANCER CELL BIOLOGIST – Postdoc – Human BioMolecular Research Institute (HBRI) – San Diego, CA

A postdoc/staff position to enhance professional development of the scientist; help conduct research within the area of active research of Senior or Staff…From Human BioMolecular Research Institute (HBRI) – Fri, 01 Oct 2021 06:14:07 GMT […]

No Picture
News

Regulus Therapeutics’ Director David Baltimore Receives 2021 Lasker-Koshland Special Achievement Award in Medical Science

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that David Baltimore, Ph.D., a director of Regulus, is the recipient of the 2021 Lasker-Koshland Special… Click here to view original post… […]

No Picture
News

Looking Beyond DNA to See Cancer with New Clarity

In three Science papers, UC San Diego and UC San Francisco researchers mapped out how hundreds of gene mutations involved in cancer affect the discrete groups of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments…. Click here to view original post… […]

No Picture
News

Salk Assistant Professor Graham McVicker receives Genomic Innovator Award

LA JOLLA—Salk Assistant Professor Graham McVicker has been awarded a National Human Genome Research Institute (NHGRI) Genomic Innovator Award, which supports early-career scientists who conduct innovative, creative research in genomics. The award, which provides $2.85 million over five years, is in recognition of McVicker’s efforts using computational and experimental… Click here to view original post… […]

No Picture
News

Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today that updated interim results from a Phase 1/2a clinical study of its lead product candidate, OpRegen®, an investigational retinal pigment epithelium cell transplant… Click here to view original post… […]

No Picture
News

Biologica Technologies® announces the presentation of ProteiOS® clinical data at the North American Spine Society 36th Annual Meeting in Boston

CARLSBAD, Calif.: CARLSBAD, Calif., Sept. 30, 2021 /PRNewswire/ — Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today the podium presentation, ‘Retrospective assessment of radiographic outcomes after implantation of a novel allograft growth factor combined with scaffold in patients undergoing XLIF, LLIF, and… Click here to view original post… […]

No Picture
News

Illumina Expands Presence in Latin America

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología marking our commitment to expand genomics in Latin America and increase the level of support for our local customers and partners. "Colombia is the… Click here to view original post… […]

No Picture
News

Evofem Biosciences to Present at LD Micro Investor Conference on October 12, 2021

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier will present and host one-on-one meetings at the 14th annual LD Micro Main Event being held in Los Angeles on October 12-14, 2021. Date: Tuesday, October 12, 2021… Click here to view original post… […]

No Picture
News

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

SAN DIEGO: SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (Nasdaq: PPD), a leading global contract research organization (CRO), for PPD to… Click here to view original post… […]

No Picture
News

Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress

SAN DIEGO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that it will present new clinical and non-clinical data in two poster presentations at the 10th… Click here to view original post… […]

No Picture
Uncategorized

Senior Scientist, Machine Learning, Computational Biology in Cell Therapy – Bristol Myers Squibb – San Diego, CA

The candidate will closely collaborate with Cell Therapy Development and Operations (CTDO) and Manufacturing Science and Technology (MSAT) colleagues in Seattle…From Bristol-Myers Squibb – Thu, 30 Sep 2021 02:02:16 GMT – View all San Diego, […]